- Home
- ESPR vs NYMT Comparison
ESPR vs NYMT Comparison
Compare ESPR & NYMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NYMT
- Stock Information
- Founded
- ESPR 2008
- NYMT 2003
- Country
- ESPR United States
- NYMT United States
- Employees
- ESPR N/A
- NYMT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NYMT Real Estate Investment Trusts
- Sector
- ESPR Health Care
- NYMT Real Estate
- Exchange
- ESPR Nasdaq
- NYMT Nasdaq
- Market Cap
- ESPR 456.6M
- NYMT 528.9M
- IPO Year
- ESPR 2013
- NYMT 2004
- Fundamental
- Price
- ESPR $2.49
- NYMT $6.20
- Analyst Decision
- ESPR Buy
- NYMT Buy
- Analyst Count
- ESPR 3
- NYMT 5
- Target Price
- ESPR $8.17
- NYMT $7.88
- AVG Volume (30 Days)
- ESPR 5.4M
- NYMT 894.1K
- Earning Date
- ESPR 11-07-2024
- NYMT 10-30-2024
- Dividend Yield
- ESPR N/A
- NYMT 13.29%
- EPS Growth
- ESPR N/A
- NYMT N/A
- EPS
- ESPR N/A
- NYMT N/A
- Revenue
- ESPR $295,451,000.00
- NYMT $252,541,000.00
- Revenue This Year
- ESPR $184.74
- NYMT N/A
- Revenue Next Year
- ESPR $34.37
- NYMT $26.56
- P/E Ratio
- ESPR N/A
- NYMT N/A
- Revenue Growth
- ESPR 187.12
- NYMT 139.48
- 52 Week Low
- ESPR $1.16
- NYMT $5.14
- 52 Week High
- ESPR $3.40
- NYMT $9.67
- Technical
- Relative Strength Index (RSI)
- ESPR 61.63
- NYMT 61.82
- Support Level
- ESPR $2.02
- NYMT $5.97
- Resistance Level
- ESPR $2.62
- NYMT $6.17
- Average True Range (ATR)
- ESPR 0.17
- NYMT 0.16
- MACD
- ESPR 0.02
- NYMT 0.04
- Stochastic Oscillator
- ESPR 80.83
- NYMT 91.84
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.